Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Adherence to HIV treatment regimens: systematic literature review and meta-analysis.

Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC.

Patient Prefer Adherence. 2019 Apr 3;13:475-490. doi: 10.2147/PPA.S192735. eCollection 2019. Review.

2.

A Case of Thoracic Endometriosis Syndrome Presenting with Recurrent Catamenial Pneumothorax.

Junejo SZ, Singh Lubana S, Shina SS, Tuli SS.

Am J Case Rep. 2018 May 17;19:573-576. doi: 10.12659/AJCR.907964.

3.

Invasive breast cancer treated with taxol and epirubicin neo-adjuvant chemotherapy: the role in the outcome of the "crosstalk" between Erb receptors and p53.

Sarid D, Ron IG, Shoshan L, Barnea I, Shina S, Baratz M, Greenberg J, Merimsky O, Ben-Yosef R, Lev-Ari S, Keidar Y, Yaal-Hahoshen N.

Anticancer Res. 2008 Sep-Oct;28(5B):3147-52.

4.

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.

Soria G, Yaal-Hahoshen N, Azenshtein E, Shina S, Leider-Trejo L, Ryvo L, Cohen-Hillel E, Shtabsky A, Ehrlich M, Meshel T, Keydar I, Ben-Baruch A.

Cytokine. 2008 Oct;44(1):191-200. doi: 10.1016/j.cyto.2008.08.002. Epub 2008 Sep 13.

PMID:
18790652
5.

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients.

Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, Greenberg I, Keydar I, Ben-Baruch A.

Clin Cancer Res. 2006 Aug 1;12(15):4474-80. Review.

6.

Influence of the diet components on the symbiotic microorganisms community in hindgut of Coptotermes formosanus Shiraki.

Tanaka H, Aoyagi H, Shiina S, Doudou Y, Yoshimura T, Nakamura R, Uchiyama H.

Appl Microbiol Biotechnol. 2006 Aug;71(6):907-17. Epub 2006 Mar 7. Erratum in: Appl Microbiol Biotechnol. 2006 Aug;71(6):970. Shina, Syunsuke [corrected to Shiina, Shunsuke]; Dodo, Yuri [corrected to Doudou, Yuri].

PMID:
16520926
7.

A novel protein derived from the MUC1 gene by alternative splicing and frameshifting.

Levitin F, Baruch A, Weiss M, Stiegman K, Hartmann ML, Yoeli-Lerner M, Ziv R, Zrihan-Licht S, Shina S, Gat A, Lifschitz B, Simha M, Stadler Y, Cholostoy A, Gil B, Greaves D, Keydar I, Zaretsky J, Smorodinsky N, Wreschner DH.

J Biol Chem. 2005 Mar 18;280(11):10655-63. Epub 2004 Dec 28.

8.

The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors.

Azenshtein E, Meshel T, Shina S, Barak N, Keydar I, Ben-Baruch A.

Cancer Lett. 2005 Jan 10;217(1):73-86.

PMID:
15596298
9.

Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia.

Mollee P, Arthur C, Hughes T, Januszewicz H, Grigg A, Bradstock K, Wolf M, Gibson J, Schwarer AP, Spencer A, Browett P, Hawkins T, Seldon M, Herrmann R, Watson A, Seymour JF, Martin N, Shina S, Low C, Wright S, Rodwell R, Coulston J, Morton J, Blacklock H, Taylor D, Taylor KM.

Ann Oncol. 2004 Dec;15(12):1810-5.

PMID:
15550587
10.

Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.

Wigler N, Shina S, Kaplan O, Luboshits G, Chaitchik S, Keydar I, Ben-Baruch A.

Isr Med Assoc J. 2002 Nov;4(11 Suppl):940-3.

PMID:
12455185
11.

The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M, Wigler N, Keydar I, Ben-Baruch A.

Cancer Res. 2002 Feb 15;62(4):1093-102.

12.

[Percutaneous tumor ablation therapy for hepatocellular carcinoma: current status and future perspective].

Shina S.

Nihon Shokakibyo Gakkai Zasshi. 2001 Jul;98(7):809-13. Japanese. No abstract available.

PMID:
11510082
13.

Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.

Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Lifshitz-Mercer B, Chaitchik S, Keydar I, Ben-Baruch A.

Cancer Res. 1999 Sep 15;59(18):4681-7.

14.

Topical interferon alpha 2b for corneal haze after excimer laser photorefractive keratectomy. The Melbourne Excimer Laser Group.

Gillies MC, Garrett SK, Shina SM, Morlet N, Taylor HR.

J Cataract Refract Surg. 1996 Sep;22(7):891-900.

PMID:
9041079
15.

Delayed expansion of V delta 2+ and V delta 1+ gamma delta T cells after acute Plasmodium falciparum and Plasmodium vivax malaria.

Schwartz E, Shapiro R, Shina S, Bank I.

J Allergy Clin Immunol. 1996 Jun;97(6):1387-92.

PMID:
8648036
16.

A case of malignant lymphoma in the liver treated by percutaneous ethanol injection therapy under peritoneoscopic observation.

Shina S, Yoshiura K, Komatsu Y, Hamada E, Niwa Y, Hata Y, Kurita M, Kawabe T, Kawase T, Ota S, et al.

Gastroenterol Jpn. 1991 Oct;26(5):674-7.

PMID:
1836441
17.

Ultrasound-guided percutaneous injection of ethanolamine oleate for hypersplenism. An experimental study in dogs.

Shina S, Aoyama H, Shiratori Y, Mutoh H, Kurita M, Ota S, Terano A, Sugimoto T.

Invest Radiol. 1990 Jun;25(6):651-7.

PMID:
2191934
18.

[Utility of optical card on patient information].

Shina S, Nishibori M, Matsuto T.

Rinsho Byori. 1990 Apr;Spec No 84:12-21. Japanese. No abstract available.

PMID:
2362359

Supplemental Content

Support Center